Monocyclic N-aryl hydantoin modulators of androgen receptor function

   
   

The present invention relates to novel compounds useful in the treatment of androgen receptor associated conditions, such as age-related diseases, pharmaceutical compositions containing at least one of the compounds of the present invention and methods of treating a patient in need of therapy for an androgen receptor associated condition by administering a therapeutically effective amount of at least compound of the present invention.

 
Web www.patentalert.com

< Methods for treating conditions, disorders, or diseases involving cell death

< Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders

> Triazole compounds

> Compounds

~ 00194